Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2025, TransMedics (TMDX) reported revenue of $143.54 million, up 48.2% over the same period last year. EPS came in at$ 0.70, compared to $0.35 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 123.56 million, representing a surprise of +16.17%. The company delivered an EPS surprise of +141.38%, with the consensus EPS estimate being $0.29.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...